how were glp 1 drugs discovered Discovery of GLP-1–Based for the Treatment of Obesity Timeline of critical milestones in

In December 2024 tirzepatide was approved by the FDA for the treatment of moderate to severe obstructive sleep apnea in adults with obesity

Zydus Cadila (2020) Worlds first drug for the treatment of Non-Cirrhotic NASH

Some people find it helpful to: Gastroparesis can be mild to severe, and so can its effect on your quality of life

Better glycemic control, remission of diabetes, reduction of cardiovascular and renal risks, and lower mortality

The findings deliver early evidence that semaglutide may offer a dual benefit, targeting obesity and key reproductive challenges associated with the condition, including irregular menstruation and impaired fertility. Clare Thompson, MBBS, BSc, nMRCGP Separately, a review of five randomized controlled trials presented at ENDO 2026 found that GLP-1 drugs, such as semaglutide and liraglutide, do not appear to harm male fertility and may even improve testosterone levels and sperm quality in some men with obesity